Tandem Diabetes Care, based in San Diego, focuses on products for insulin-dependent diabetes, employing 2,400 staff since its IPO in 2013. Its advanced insulin pumps, including the t:slim X2, feature Control-IQ technology and are compatible with various CGM sensors.
TNDM has been in the news recently: Tandem Diabetes Care, Inc. is under investigation by Rosen Law Firm for potentially misleading information following a 19.9% drop in its stock on August 7, 2025. Additionally, other major firms, such as XYZ Corp, reported a 15% increase in revenue this quarter due to strong sales and market expansion.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.